Myelodysplastic syndrome
Disease
Advanced Leukemia Successfully Treated With First Use Of Antibody And Stem Cell Transplantation...Pagel said. Older (over age 50) patients with active, advanced leukemia and myelodysplastic syndrome pose the most difficult treatment challenges because standard transplant therapy rarely works, according to Pagel. Both standard and... In this article: Leukemia, CD45, Myelodysplastic syndrome, Antibody, Medical advice, Iodine, University of Washington School of Medicine, and Chronic myelogenous leukemia |
-
New Kerala | November 05, 2009
New therapy shows promise in treating advanced leukemia
...and assistant member of the Hutchinson Center''s Clinical Research Division, patients over the age of 50 with active, advanced leukemia and myelodysplastic syndrome pose the most difficult treatment challenges because standard transplant...
In this article: Leukemia, Acute myeloid leukemia, and Washington
-
PR Newswire: Health / Biotech | November 05, 2009
InterMune Announces Appointments of Senior Leadership to Prepare for Potential Launch of Pirfenidone
...the commercial organization and the successful launch of Vidaza®, a chemotherapeutic agent for treating myelodysplastic syndrome and some types of leukemia. She later was promoted to Executive Director, Strategic Commercial Operations at...
In this article: Europe, FDA, United States, Genentech, Celgene, SEC, Novartis, and EU
-
Baltimore Sun | August 02, 2009
Morris Katz, Wise Products founder
...Products founder Morris Katz, founder of Wise Products Distributors whose "Peppy the Owl" sign was an Aliceanna Street landmark, died Monday of myelodysplastic syndrome, a pre-leukemia, at Northwest Hospital Center. He was 92. Mr. Katz,...
In this article: Passaic, Baltimore, New Jersey, and World War II
-
bizjournals: Local Business News | November 05, 2009
InterMune submits IPF drug for approval
...vice president of sales, who most recently with Celgene. She led the launch of Vidaza, a chemotherapy agent for treating myelodysplastic syndrome and some types of leukemia. Also joining InterMune as vice president of marketing is Erik...
In this article: Europe, Revenue, Bristol-Myers Squibb, Food and Drug Administration, United States, and Tax
-
Wikipedia | August 15, 2009
Sideroblastic anemia
...anemia Sideroblastic anemia is caused by abnormal production of ringed sideroblasts, caused either genetically or indirectly as part of myelodysplastic syndrome, which can evolve into hematological malignancies (especially acute...
In this article: Sideroblastic anemia, Leukemia, Vitamin B6, Lead poisoning, Iron deficiency, Medline, Synthase, Isoniazid, and Heart failure
-
Detroit Free Press | July 14, 2009
People making news
...and clinical pathology and hematology. His interests include lymphoma, leukemia, myelodysplastic syndrome, myeloproliferative neoplasia, hemoglobinopathy/thalassemia and medical microscopy. Schwimer is board certified in pathology and...
In this article: Corporate governance, Web-based, Leukemia, and Thalassemia
-
Medical News Today | January 01, 2009
EU Grants VIDAZA® Full Marketing Authorization For The Treatment Of Patients With Higher-Risk Myelodysplastic Syndromes And Acute Myeloid Leukaemi
EU Grants VIDAZA® Full Marketing Authorization For The Treatment Of Patients With Higher-Risk Myelodysplastic Syndromes And Acute Myeloid Leukaemi Lymphoma / Leukemia News EU Grants VIDAZA® Full Marketing Authorization For The Treatment Of...
In this article: Cancer, Myelodysplastic, European Union, Myeloid, FDA, Thrombocytopenia, Acute Myeloid Leukaemia, and Celgene Corporation
-
www.washingtonpost.com | January 14, 2007
Musician Michael Brecker; Won 11 Grammy Awards
...pianist Herbie Hancock and trumpeter Roy Hargrove, among others, and toured prolifically until in May 2005 he received a diagnosis of myelodysplastic syndrome, a blood and bone-marrow disease that ultimately gave way to his leukemia.
In this article: Michael Brecker, Grammy Award, Randy Brecker, Barry Rogers, McCoy Tyner, Brecker Brothers, Leukemia, Horace Silver, and New York
-
Medical News Today | July 02, 2008
Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial Of Dacogen(R) Versus Supportive Care In Patients With Myelodysplastic Syndromes
Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial Of Dacogen(R) Versus Supportive Care In Patients With Myelodysplastic Syndromes Lymphoma / Leukemia News Eisai Provides Preliminary Efficacy Update On EORTC Phase III...
In this article: Decitabine, Myelodysplastic, Eisai Co., Ltd., Leukemia, Fiscal year, Thrombocytopenia, Hydroxyurea, Chronic myelogenous leukemia, and Cancer
Trends
Loading...
More on Myelodysplastic syndrome
Description from Wikipedia:
The myelodysplastic syndromes (MDS, formerly known as "preleukemia") are a diverse collection of hematological conditions united by ineffective production (or dysplasia) of myeloid blood cells and risk of transformation to acute myelogenous leukemia (AML). Anemia requiring chronic blood transfusion is frequently present.
Myelodysplastic syndromes are bone marrow stem cell disorders resulting in disorderly and ineffective hematopoiesis (blood production) manifested by irreversible quantitative and qualitative defects in hematopoietic (blood-forming) cells. In a majority of cases, the course of disease is chronic with gradually worsening cytopenias due to progressive bone marrow failure. Approximately one-third of patients with MDS progress to AML within months to a few years.
Explore everything named Myelodysplastic syndrome...